http://web.archive.org/web/20100621075146id_/http://www.cnn.com:80/2010/HEALTH/06/16/female.viagra/

-- a @entity2 review of data on the effectiveness of flibanserin -- a pill anticipated to become the first " female viagra " -- resulted in questions about how well the drug will actually work in treating premenopausal women suffering from low sex drive			1
according to a report posted on the @entity2 website wednesday , when compared with a placebo , the response rate of @entity13 was " not compelling , " and the drug yielded only slight improvements for treating hypoactive sexual desire disorder or @entity20			1
on friday , an @entity2 committee composed of reproductive health experts will be voting on the efficacy and safety of @entity13 for use in women with low desire -- a sexual disorder that could impact nearly 40 percent of women in the @entity30 , according to some estimates			1
currently , there is no medication approved to treat @entity20 in women			0
a spokesperson for @entity37 - based @entity36 , the manufacturer of flibanserin , says the company is still optimistic			0
" we remain confident that our data demonstrates @entity13 is safe and effective in balancing the chemicals in the brain linked to sexual desire , " says @entity40 , executive director of @entity30 medical affairs for @entity36			1
" we have conducted a robust program showing that flibanserin shows improvement increasing satisfying sexual events , in improving sexual desire and lowering distress , " he adds			2
even if the data show only " slight improvements , " the benefits of approving the drug are vast , contends dr. @entity56 , director of sexual medicine at @entity58 in @entity59 , @entity60			0
" hsdd is a horrible tragedy in women , " says @entity56 , who treats patients suffering from low sex drive , and who has also been on the drug manufacturer 's international advisory committee for several years			0
he says flibanserin would be " the beginning of an era " for women , and that having a safe and effective drugs is a " unique and historic opportunity for women in the @entity30 and for the @entity2			2
" @entity0 's @entity75 contributed to this report .			0

@entity13 anticipated as ' female @entity7 '
@entity2 review says results " not compelling "
@entity2 committee votes friday on @entity13
some estimates say nearly 40 percent of @entity30 women have low sexual desire

@entity2:FDA
@entity20:HSDD
@entity0:CNN
@entity13:Flibanserin
@entity37:Germany
@entity30:American
@entity36:Boehringer Ingelheim
@entity40:Peter Piliero
@entity56:Goldstein
@entity75:Miriam Falco
@entity7:Viagra
@entity59:San Diego
@entity58:Alvarado Hospital
@entity60:California